Tag: DEA

DEA registration validation changes challenge healthcare accreditation

Editor's Note Since February 2024, changes to the Registrant Validation Toolset from the Drug Enforcement Administration (DEA) have introduced new hurdles for healthcare organizations, MedTrainer October 2024 reports. The updates, which aim to prevent fraud by adding multi-factor authentication, are causing compliance challenges during primary source verification (PSV). Credentialers are…

Read More

By: Tarsilla Moura
October 9, 2024
Share

National prescription drug 'Take Back Day' is October 28

The Federal Drug Enforcement Administration (DEA) has announced that the National Prescription Drug 'Take Back Day' is this Saturday, October 28. The day allows the public to dispose safely of prescription drugs. On that day, the public is invited to dispose of unneeded medications at almost 5,000 local drop-off locations nationwide,…

Read More

By: Brita Belli
October 23, 2023
Share

Prepare for DEA inspections, controlled substances oversight

The headlines are attention grabbing: hospitals forced to pay millions of dollars after employees were found to have stolen opioids and other controlled substances. After being discovered and investigated by the Drug Enforcement Agency (DEA), the agents uncovered a number of issues: poor record-keeping, inventory, tracking, and other failures that…

Read More

By: Brita Belli
February 22, 2023
Share

AHA urges DEA to extend virtual prescribing rules, substance use medication

Editor's Note The American Hospital Association (AHA) sent a special request to the Drug Enforcement Administration (DEA) on December 1 asking to clarify and extend rules that were created during COVID-19, which allowed providers to virtually prescribe medication for addiction-treatment, Becker’s Hospital Review December 2 reports. During the pandemic, providers…

Read More

By: Bridget Brown
December 5, 2022
Share

Session: Proper Tactics to Prepare for a DEA Inspection

Editor's Note “Is your OR ready for a DEA [Drug Enforcement Administration] inspection?” was the question Dennis Wichern, MBA, partner at Prescription Drug Consulting, asked attendees of this breakout session. As a retired DEA agent, Wichern discussed the ways the DEA has been involved in the medical field, specifically pertaining…

Read More

By: Bridget Brown
October 19, 2022
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat